The Effect of Medication Reminder Chart on Level Adherence in diabetes mellitus type 2 patients at RSUD Sleman Yogyakarta

Yunita Suffiana, Fita Rahmawati, Tri Murti Andayani
































Diabetes is a chronic disease which requires long-term treatment. The complexity of therapeutic regiments and long term treatment could lead to poor adherence. Patient adherence is a key factor that determines the outcome of diabetes mellitus therapy. This study was conducted to determine the effect of a medication reminder chart on level adherence and clinical outcome in patients with Type 2 diabetes mellitus.

The experimental study used pretest-posttest design with control group was conducted during February until April of 2016 at Sleman Hospital in Yogyakarta. Patients were categorized into two groups of different subjects, who received of medication reminder chart tools were 40 patients and the other 40 patients were assigned to control group. Grouping patients with randomized allocation sampling with six block sequence combination. Code A for Medication Reminder Chart and code B for control groups. Morisky Medication Adherence Scale of 8-item (MMAS-8) was used to measure adherence. Clinical outcome were measured based on FBG decrease (mg/dl). Measurement of levels adherence and clinical outcomes conducted before and after the intervention. Statistical analysis of data was done using two independent sample to determine the mean differences in the average score of the adherence level before and after using the medication reminder chart.

The results of this study showed that Medication Reminder Chart compared control groups improved adherence (p = 0.000) but did not improve clinical outcome (p = 0.411). Increased compliance could increase clinical outcome (p = 0.029), with a positive correlation and the strength of weak correlation (r = 0.213).


Keywords: Compliance, Clinical outcome, MMAS-8, Medication Reminder Chart





















BPOM, 2006. Kepatuhan Pasien : Faktor Penting Dalam Keberhasilan Terapi. Badan POM Republik Indonesia, Jakarta.

Cramer, J.A., 2004. A Systematic Review of Adherence With Medications for Diabetes. Diabetes Care, 27: 1218–1224.

CDC, 2009. The Power of Prevention Chronic disease the public health challenge of the 21st century.

Divya, S. dan Nadig, P., 2015. Factors Contributing To Non-Adherence To Medication among Type 2 Diabetes Mellitus In Patients Attending Tertiary Care Hospital In South India. Asian Journal of Pharmaceutical and Clinical Research, 8:

Lam.W.Y., Paula, F., Medication Adherence Measures: An Overview, BioMed Research International Volume 2015, Article ID 217047, 12 pages

Morisky, D.E., Ang, A., Krousel-Wood, M., dan Ward, H.J., 2008. Predictive Validity of A Medication Adherence Measure in an Outpatient Setting. Journal of clinical hypertension (Greenwich, Conn.), 10: 348–354

Conn, V.S., Hafdahl, A.R., Cooper, P.S., Ruppar, T.M., Mehr, D.R., dan Russell, C.L., 2009. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. The Gerontologist, 49: 447–462.

Dinas Kesehatan Kabupaten Sleman, 2013, Profil Kesehatan Sleman 2013 Sub Bagian Perencanaan dan Evaluasi, Sleman.

Santosa, M., 2011, Pengenalan Penyakit DM Dan Penanganannya Dewasa ini, tanggal 25 januari 2016)

Wells, B.G., Dipiro, J.T., Schwinghammmer, T.L., dan Dipiro, C.V., 2009. Pharmacotherapy Handbook.McGraw-Hill Medical Pub.Division, New York.



  • There are currently no refbacks.

Indonesian J Pharm indexed by: